rss Posted July 16, 2014 Report Share Posted July 16, 2014 British Journal of Dermatology, 2012 166, pp 633–641 Once-daily topical brimonidine tartrate gel 0Æ5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies J. Fowler, M. Jarratt, A. Moore, K. Meadows, A. Pollack, M. Steinhoff, Y. Liu and M. Leoni, on behalf of the Brimonidine Phase II Study Group Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now